Prot #TA799‐012: An Open‐label Extension Trial to Evaluate the Long‐term Safety of Apraglutide in Short Bowel Syndrome

Project: Research project

Project Details

StatusActive
Effective start/end date8/31/23 → 8/31/26

Funding

  • PSI Pharma Support America Inc. (Prot #TA799-012 // Prot #TA799-012)
  • VectivBio AG (Prot #TA799-012 // Prot #TA799-012)